Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC

NCT02835924 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

299

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Regorafenib

Sponsor

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Collaborators

[object Object]